115 related articles for article (PubMed ID: 20034525)
1. Functional characterization of two human receptor activity-modifying protein 3 variants.
Bailey RJ; Bradley JW; Poyner DR; Rathbone DL; Hay DL
Peptides; 2010 Apr; 31(4):579-84. PubMed ID: 20034525
[TBL] [Abstract][Full Text] [Related]
2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
3. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
5. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
6. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
[TBL] [Abstract][Full Text] [Related]
7. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
8. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
[TBL] [Abstract][Full Text] [Related]
10. N-Glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CRLR/RAMP3 adrenomedullin receptor.
Flahaut M; Pfister C; Rossier BC; Firsov D
Biochemistry; 2003 Sep; 42(34):10333-41. PubMed ID: 12939163
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
12. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
13. A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor.
Gingell JJ; Qi T; Bailey RJ; Hay DL
Peptides; 2010 Jul; 31(7):1400-4. PubMed ID: 20347903
[TBL] [Abstract][Full Text] [Related]
14. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
[TBL] [Abstract][Full Text] [Related]
15. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
16. Diverse functional motifs within the three intracellular loops of the CGRP1 receptor.
Conner AC; Simms J; Conner MT; Wootten DL; Wheatley M; Poyner DR
Biochemistry; 2006 Oct; 45(43):12976-85. PubMed ID: 17059214
[TBL] [Abstract][Full Text] [Related]
17. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
18. Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Kato J
Biochem Biophys Res Commun; 2010 Feb; 392(3):380-5. PubMed ID: 20074556
[TBL] [Abstract][Full Text] [Related]
19. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
Granholm S; Lundberg P; Lerner UH
J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
Ittner LM; Koller D; Muff R; Fischer JA; Born W
Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
